GSK1820795A, as a telmisartan analog, is a selective hGPR132a antagonist. GSK1820795A blocks activation of yeast cells expressing hGPR132a by N-acylamides GSK1820795A is also a angiotensin II antagonists and partial PPARγ agonists (compound 38) .
In Vitro
GSK1820795A blocks responses of yeast expressing hGPR132a to agonists NPGly, NLGly, linoleamide, and SB-583831. MCE has not independently confirmed the accuracy of these methods. They are for reference only.